Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-15

Clinical Trial Update: Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is ongoing to evaluate tranexamic acid for reducing transfusion requirements in abdominal surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Ulrich Ronellenfitsch, MD | Conditions: Surgical Blood Loss, Transfusion-dependent Anemia | Phase 3 | Status: RECRUITING